Related Experiment Video
Updated: Sep 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson's disease
Rebecca Ting Jiin Loo1, Lukas Pavelka2, Graziella Mangone3
1Biomedical Data Science Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Abstract:
Cognitive impairment is a frequent complication of Parkinson's disease (PD), affecting up to half of newly diagnosed patients. To improve early detection and risk assessment, we developed machine learning models using clinical data from three independent PD cohorts, which are (LuxPARK, PPMI, ICEBERG). Models were trained to predict mild cognitive impairment (PD-MCI) and subjective cognitive decline (SCD) using Explainable Artificial Intelligence (XAI) for classification and time-to-event analysis. Multi-cohort models showed greater performance stability over single-cohort models, while retaining competitive average performance. Age at diagnosis and visuospatial ability were identified as key predictors. Significant sex differences observed highlight the importance of considering sex-specific factors in cognitive assessment. Men were more likely to report SCD. Our findings highlight the potential of multi-cohort machine learning for early identification and personalized management of cognitive decline in PD.
More Related Videos
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood